InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Timothy Rolph, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 34 open-market SEC Form 4 transactions: 0 purchases worth $0 and 34 sales worth $13.8M, reported from Sep 13, 22 to Oct 7, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 7, 25 | AKROAkero Therapeutics, Inc. | SELL | 11.5K | $46.82 | $527K |
| Sep 11, 25 | AKROAkero Therapeutics, Inc. | SELL | 553 | $43.02 | $24K |
| Sep 8, 25 | AKROAkero Therapeutics, Inc. | SELL | 12.5K | $44.88 | $551K |
| Aug 5, 25 | AKROAkero Therapeutics, Inc. | SELL | 7.0K | $49.49 | $345K |
| Jul 7, 25 | AKROAkero Therapeutics, Inc. | SELL | 10.6K | $52.62 | $542K |
| Jun 18, 25 | AKROAkero Therapeutics, Inc. | SELL | 1.1K | $54.84 | $62K |
| Jun 10, 25 | AKROAkero Therapeutics, Inc. | SELL | 2.4K | $54.00 | $127K |
| Jun 6, 25 | AKROAkero Therapeutics, Inc. | SELL | 25.0K | $55.04 | $1.4M |
| Jun 5, 25 | AKROAkero Therapeutics, Inc. | SELL | 9.3K | $53.84 | $499K |
| May 6, 25 | AKROAkero Therapeutics, Inc. | SELL | 8.7K | $44.50 | $379K |
| Apr 24, 25 | AKROAkero Therapeutics, Inc. | SELL | 6.3K | $41.03 | $256K |
| Apr 7, 25 | AKROAkero Therapeutics, Inc. | SELL | 3.8K | $37.92 | $135K |
| Mar 12, 25 | AKROAkero Therapeutics, Inc. | SELL | 516 | $44.88 | $23K |
| Mar 5, 25 | AKROAkero Therapeutics, Inc. | SELL | 9.3K | $44.90 | $415K |
| Feb 5, 25 | AKROAkero Therapeutics, Inc. | SELL | 12.8K | $56.92 | $724K |
| Jan 27, 25 | AKROAkero Therapeutics, Inc. | SELL | 13.8K | $56.97 | $756K |
| Dec 17, 24 | AKROAkero Therapeutics, Inc. | SELL | 3.8K | $31.10 | $118K |
| Dec 10, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.5K | $31.03 | $76K |
| Sep 10, 24 | AKROAkero Therapeutics, Inc. | SELL | 537 | $26.18 | $14K |
| Jun 11, 24 | AKROAkero Therapeutics, Inc. | SELL | 2.4K | $22.64 | $54K |
| Mar 13, 24 | AKROAkero Therapeutics, Inc. | SELL | 619 | $28.33 | $18K |
| Dec 14, 23 | AKROAkero Therapeutics, Inc. | SELL | 514 | $20.76 | $11K |
| Sep 13, 23 | AKROAkero Therapeutics, Inc. | SELL | 531 | $50.34 | $27K |
| Jun 16, 23 | AKROAkero Therapeutics, Inc. | SELL | 49.3K | $56.30 | $2.7M |
| Jun 13, 23 | AKROAkero Therapeutics, Inc. | SELL | 509 | $55.16 | $28K |
| Dec 29, 22 | AKROAkero Therapeutics, Inc. | SELL | 12.3K | $51.38 | $632K |
| Dec 28, 22 | AKROAkero Therapeutics, Inc. | SELL | 1.7K | $50.00 | $85K |
| Nov 16, 22 | AKROAkero Therapeutics, Inc. | SELL | 3.8K | $46.05 | $175K |
| Nov 15, 22 | AKROAkero Therapeutics, Inc. | SELL | 3.1K | $45.04 | $141K |
| Oct 26, 22 | AKROAkero Therapeutics, Inc. | SELL | 4.8K | $45.03 | $214K |
| Oct 25, 22 | AKROAkero Therapeutics, Inc. | SELL | 10.7K | $45.09 | $480K |
| Oct 6, 22 | AKROAkero Therapeutics, Inc. | SELL | 22.5K | $39.29 | $884K |
| Sep 30, 22 | AKROAkero Therapeutics, Inc. | SELL | 22.5K | $34.06 | $766K |
| Sep 13, 22 | AKROAkero Therapeutics, Inc. | SELL | 22.5K | $29.18 | $657K |